Over the past 12 months, 3 insiders at Sensei Biotherapeutics, Inc. filed 69 open-market SEC Form 4 transactions on SNSE: 25 purchases worth $1.3M and 44 sales worth $2.3M. Insiders have been net sellers over this period. The most recent filing was on Jun 1, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 26 | Cambrian Biopharma Inc | SELL | 24.5K | $21.14 | $490K |
| Jun 1, 26 | James Peyer | SELL | 24.5K | $21.14 | $490K |
| Apr 7, 26 | Millennium Management Llc | BUY | 1.1K | $33.38 | $37K |
| Apr 7, 26 | Millennium Management Llc | SELL | 4.4K | $33.38 | $139K |
| Apr 6, 26 | Millennium Management Llc | BUY | 1.1K | $31.02 | $34K |
| Apr 6, 26 | Millennium Management Llc | SELL | 1.2K | $31.96 | $38K |
| Apr 2, 26 | Millennium Management Llc | BUY | 1.3K | $35.55 | $44K |
| Apr 2, 26 | Millennium Management Llc | SELL | 3.1K | $34.80 | $96K |
| Apr 1, 26 | Millennium Management Llc | BUY | 3.4K | $35.46 | $121K |
| Apr 1, 26 | Millennium Management Llc | SELL | 1.1K | $34.75 | $35K |
| Mar 31, 26 | Millennium Management Llc | BUY | 2.0K | $32.60 | $62K |
| Mar 31, 26 | Millennium Management Llc | SELL | 1.3K | $31.52 | $31K |
| Mar 30, 26 | Millennium Management Llc | BUY | 5.0K | $27.68 | $130K |
| Mar 30, 26 | Millennium Management Llc | SELL | 518 | $27.68 | $13K |
| Mar 27, 26 | Millennium Management Llc | BUY | 10.6K | $28.13 | $280K |
| Mar 27, 26 | Millennium Management Llc | SELL | 469 | $27.37 | $13K |
| Mar 26, 26 | Millennium Management Llc | BUY | 2.6K | $29.98 | $75K |
| Mar 26, 26 | Millennium Management Llc | SELL | 1.3K | $28.69 | $37K |
| Dec 9, 25 | Cambrian Biopharma IncTenPercentOwner | SELL | 3.1K | $8.59 | $27K |
| Dec 9, 25 | James PeyerTenPercentOwner,Other | SELL | 2.7K | $8.04 | $21K |
| Dec 8, 25 | James PeyerTenPercentOwner,Other | SELL | 3.1K | $8.59 | $27K |
| Dec 5, 25 | Cambrian Biopharma IncTenPercentOwner | SELL | 14.5K | $13.16 | $165K |
| Dec 5, 25 | James PeyerTenPercentOwner,Other | SELL | 14.5K | $13.16 | $165K |
| Dec 4, 25 | Cambrian Biopharma IncTenPercentOwner | SELL | 5.0K | $9.06 | $45K |
| Dec 4, 25 | James PeyerTenPercentOwner,Other | SELL | 5.0K | $9.06 | $45K |
| Sep 11, 23 | John CelebiPresident and CEO | BUY | 500 | $0.85 | $425 |
| Jun 1, 23 | Christian AngermayerTenPercentOwner | SELL | 2.49M | $1.58 | $3.9M |
| Feb 23, 23 | Apeiron Investment Group Ltd.TenPercentOwner | BUY | 1.1K | $1.62 | $2K |
| Mar 2, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 1.2K | $3.20 | $4K |
| Mar 2, 22 | James PeyerDirector,TenPercentOwner | BUY | 1.2K | $3.20 | $4K |
| Mar 1, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 2.5K | $3.60 | $9K |
| Mar 1, 22 | James PeyerDirector,TenPercentOwner | BUY | 2.5K | $3.60 | $9K |
| Feb 28, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 42 | $3.60 | $151 |
| Feb 28, 22 | James PeyerDirector,TenPercentOwner | BUY | 42 | $3.60 | $151 |
| Feb 25, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 2.5K | $3.65 | $9K |
| Feb 25, 22 | James PeyerDirector,TenPercentOwner | BUY | 2.5K | $3.65 | $9K |
| Feb 24, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 15.0K | $3.63 | $54K |
| Feb 24, 22 | James PeyerDirector,TenPercentOwner | BUY | 15.0K | $3.63 | $54K |
| Feb 23, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 2.5K | $3.80 | $10K |
| Feb 23, 22 | James PeyerDirector,TenPercentOwner | BUY | 2.5K | $3.80 | $10K |
| Feb 18, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 15.0K | $3.97 | $60K |
| Feb 18, 22 | James PeyerDirector,TenPercentOwner | BUY | 15.0K | $3.97 | $60K |
| Feb 17, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 4.9K | $4.17 | $21K |
| Feb 17, 22 | James PeyerDirector,TenPercentOwner | BUY | 4.9K | $4.17 | $21K |
| Feb 16, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 2.6K | $4.25 | $11K |
| Feb 16, 22 | James PeyerDirector,TenPercentOwner | BUY | 2.6K | $4.25 | $11K |
| Feb 14, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 10.0K | $4.18 | $42K |
| Feb 14, 22 | James PeyerDirector,TenPercentOwner | BUY | 10.0K | $4.18 | $42K |
| Feb 11, 22 | Cambrian Biopharma IncTenPercentOwner | BUY | 12.5K | $4.40 | $55K |
| Feb 11, 22 | James PeyerDirector,TenPercentOwner | BUY | 12.5K | $4.40 | $55K |
Over the past 12 months, insiders at Sensei Biotherapeutics, Inc. filed 25 open-market purchases worth $1.3M and 44 sales worth $2.3M on SNSE, which makes them net sellers over the period. The most recent Form 4 was filed on Jun 1, 26.
The largest recent open-market SNSE insider purchase in our data was $280K by Millennium Management Llc, filed on Mar 27, 26.
3 different insiders at Sensei Biotherapeutics, Inc. filed open-market SEC Form 4 transactions on SNSE over the last 12 months.
InsiderTape plots every SNSE insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Sensei Biotherapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →